Sign Up to like & get
recommendations!
0
Published in 2019 at "Hematological Oncology"
DOI: 10.1002/hon.210_2631
Abstract: to quantify sources of variability, including body size effects, on ADC and monomethyl auristatin E (MMAE) PK in paediatric pts with classical Hodgkin lymphoma (cHL). Methods: POPPK base-models were based on previously reported models. A…
read more here.
Keywords:
mdm4;
model;
auc;
based dosing ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Journal of Cellular Biochemistry"
DOI: 10.1002/jcb.27748
Abstract: Total knee arthroplasty is a commonly performed safe procedure and typically executed in severe knee arthritis, but it also triggers ischemia‐reperfusion injury (IRI). More recently, microRNAs (miRs) have been reported to play a contributory role…
read more here.
Keywords:
p53 signaling;
mdm4;
mir 23b;
signaling pathway ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "Oncogene"
DOI: 10.1038/s41388-020-1325-1
Abstract: The Mdm4 (alias MdmX) oncoprotein, like its paralogue and interaction partner Mdm2, antagonizes the tumor suppressor p53. p53-independent roles of the Mdm proteins are emerging, and we have reported the ability of Mdm2 to modify…
read more here.
Keywords:
mdm4;
dna replication;
replication;
p53 independent ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "Vascular"
DOI: 10.1177/17085381211069447
Abstract: Objective Atherosclerosis is a chronic cardiovascular disease associated with oxidative stress damage, which is caused by excessive oxidation of low-density lipoprotein (ox-LDL). The role of microRNA miR-34a-5p on oxidative stress in ox-LDL–treated macrophages was investigated…
read more here.
Keywords:
mdm4;
stress injury;
oxidative stress;
microrna mir ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "AntiCancer Research"
DOI: 10.21873/anticanres.14906
Abstract: Background/Aim: The oncoproteins murine double minute (MDM) 2 and MDM4 inactivate tumor-suppressor protein p53. Their mutual relationship with the prognosis of gastric cancer (GC) remains unknown. Patients and Methods: Expression of MDM2, MDM4, and p53…
read more here.
Keywords:
expression p53;
mdm4;
expression;
p53 ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.933446
Abstract: MDM2 and MDM4 proteins are key negative regulators of tumor suppressor p53. MDM2 and MDM4 interact via their RING domains and form a heterodimer polyubiquitin E3 ligase essential for p53 degradation. MDM4 also forms heterodimer…
read more here.
Keywords:
mdm4;
apoptosis;
mdm2 mdm4;
p53 ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Cancers"
DOI: 10.3390/cancers11091349
Abstract: Estrogen activity towards cancer-related pathways can impact therapeutic intervention. Recent omics data suggest possible crosstalk between estrogens/gender and MDM4, a key regulator of p53. Since MDM4 can either promote cell transformation or enhance DNA damage-sensitivity,…
read more here.
Keywords:
mdm4;
estrogen;
estrogens counteract;
sensitivity ... See more keywords